24 May 2013
Keywords: fda, accepts, ndas, genentech, eisai, gsk, s-p
Article | 20 February 2006
l US biotechnology major Genentech has completed the submission of a supplemental Biologics License Application to the Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 February 2006
23 May 2013
© 2013 thepharmaletter.com